VC  DCVC Bio

https://www.dcvc.com/bio/




     Office Locations:

270 University Avenue
Palo Alto, CA 94301
Phone: 415-840-7337

Get all office locations for this firm with a National Database subscription or Silicon Valley Database subscription.
 
Stages:

  • Early
  • Seed
 
Industries:

  • Food & Agriculture
  • Life Sciences & Healthcare
  • Medical Device


    		•
     
    Description:

    DCVC established DCVC Bio in 2018. Its cofounders and Managing Partners- Dr. John Hamer, Dr. Kiersten Stead, Matt Ocko, and Zachary Bogue- believe that investing in companies that can bring breakthrough medicines to the clinic, or commercialize novel life sciences products, demands specific and longtime experience at similar ventures. The firm's investment team members are experts in genetics, chemistry, molecular biology, agriculture, industrial fermentation, AI, and more. In making and supporting our investments from DCVC Bio's funds, we combine scientific acumen with the wisdom gained from decades of operational management.


     
    Funds:


      Fund Name
      Amount
      Date
    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or Silicon Valley Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)    		No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)    		$2M-$7M
    Expansion Stage
    (also called Late-stage)    		$7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     
    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    John Hamer Managing Partner
    Kiersten Stead Managing Partner
    Matthew Ocko Co-Founder and Managing Partner
    Zachary Bogue Co-Founder and Managing Partner

     
    Recent Funding Events (trailing 12 months):


      Date
      Name
      State
      Amount
      Stage

      03/13/2026
      AgZen
      MA
      $10,000,000
      Series B

      10/17/2025
      Nilo Therapeutics
      NY
      $101,000,000
      Series A

      04/09/2025
      Solu Therapeutics
      MA
      $41,000,000
      Series A

     
    Portfolio companies include:

     
    Recent News: